Investors who adopt systems thinking when approaching the space economy can enhance their ability to understand and influence ...

Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...

Master director David Cronenberg continues to explore squirm-making subjects, always thoughtfully, here with a well-cast ...

After mass layoffs, the FDA has started missing certain deadlines, pushing one biopharma to delay a phase 3 trial and ...

“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...

With tariffs pushing manufacturing home to the U.S., Pitchbook warns of reduced M&A activity and venture capital funding.

The budget proposes a massive $20 billion cut for the NIH in 2026 — roughly a 40% reduction — and a sweeping consolidation, ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

Loyal, a Bay Area biotech company has developed a new pill that could extend a dog’s life. After one year of the ...

Learn about metabolomics, biology's fourth language that has remained vastly untapped up until now and could accelerate ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Six startups introduced their tech products last week, while businesses who have been through the program explain how it ...